In CF carriers of other ethnic backgrounds, the DF508 deletion is present in:
             The type of genetic testing used to detect the DF508 deletion and other mutations is called direct testing. Current testing readily detects up to 90% of carriers in the North European Caucasian population lining in North American and 95%
             ...